These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 13536090)

  • 21. Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil.
    Liu J; Li X; Cheng YN; Cui SX; Chen MH; Xu WF; Tian ZG; Makuuchi M; Tang W; Qu XJ
    Eur J Pharmacol; 2007 Nov; 574(1):1-7. PubMed ID: 17904544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of CFU-E/BFU-E and CFU-GM colony growth by cyclophosphamide, 5-fluorouracil and taxol: development of a high-throughput in vitro method.
    Malerba I; Casati S; Diodovich C; Parent-Massin D; Gribaldo L
    Toxicol In Vitro; 2004 Jun; 18(3):293-300. PubMed ID: 15046776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the survival of Walker tumor cells in the rat subjected to therapy with antimitotic agents].
    SFORZA M; CAGLIANI P; MARINO V
    Biol Lat; 1962; 15():189-98. PubMed ID: 13988296
    [No Abstract]   [Full Text] [Related]  

  • 24. Primary peritoneal carcinosarcoma (malignant mixed mullerian tumor): Report of a case with five-year disease free survival after surgery and chemoradiation and a review of literature.
    Ko ML; Jeng CJ; Huang SH; Shen J; Tzeng CR; Chen SC
    Acta Oncol; 2005; 44(7):756-60. PubMed ID: 16227168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells.
    Banti I; Nencetti S; Orlandini E; Lapucci A; Breschi MC; Fogli S
    J Pharm Pharmacol; 2009 Aug; 61(8):1057-66. PubMed ID: 19703350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines.
    Kim JW; Kim HP; Im SA; Kang S; Hur HS; Yoon YK; Oh DY; Kim JH; Lee DS; Kim TY; Bang YJ
    Cancer Lett; 2008 Dec; 272(2):296-306. PubMed ID: 18774637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II evaluation of topotecan in carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
    Miller DS; Blessing JA; Schilder J; Munkarah A; Lee YC
    Gynecol Oncol; 2005 Aug; 98(2):217-21. PubMed ID: 15975641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinosarcoma of the ovary: 19 years of prospective data from a single center.
    Brown E; Stewart M; Rye T; Al-Nafussi A; Williams AR; Bradburn M; Smyth J; Gabra H
    Cancer; 2004 May; 100(10):2148-53. PubMed ID: 15139057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth inhibition of a human tumor cell strain by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine; reversal studies.
    RICH MA; BOLAFFI JL; KNOLL JE; CHEONG L; EIDINOFF ML
    Cancer Res; 1958 Jul; 18(6):730-5. PubMed ID: 13561271
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of heparin on circulating Walker carcinosarcoma 256 cells.
    AGOSTINO D; GROSSI CE; CLIFFTON EE
    J Natl Cancer Inst; 1961 Jul; 27():17-24. PubMed ID: 13681661
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of hyperlipemia on pulmonary metastases of Walker 256 carcinosarcoma in the rat.
    CLIFFTON EE; AGOSTINO D; MINDE K
    Cancer Res; 1961 Sep; 21():1062-7. PubMed ID: 13694102
    [No Abstract]   [Full Text] [Related]  

  • 32. Association between carcinosarcoma and the transplanted kidney.
    Buzogány I; Bagheri F; Süle N; Magyarlaki T; Kalmár-Nagy K; Farkas L; Pajor G
    Anticancer Res; 2006; 26(1B):751-3. PubMed ID: 16739348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
    Folkvord S; Flatmark K; Seierstad T; Røe K; Rasmussen H; Ree AH
    Radiother Oncol; 2008 Mar; 86(3):428-34. PubMed ID: 18006097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of triethyllead on the motile activity of walker 256 carcinosarcoma cells.
    Sroka J; Kamiński R; Michalik M; Madeja Z; Przestalski S; Korohoda W
    Cell Mol Biol Lett; 2004; 9(1):15-30. PubMed ID: 15048148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibitory effect of 5-fluorouracil on Walker carcinosarcoma transplant growth].
    CARISSIMI E; SANGIORGI G; VARGIU L
    Boll Soc Ital Biol Sper; 1958 Mar; 34(6):285-7. PubMed ID: 13536090
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of cancer inhibitor drugs on the take of Walker carcinosarcoma 256 in rats.
    MCDONALD GO; CRUZ EP; COLE WH
    Surg Forum; 1957; 7():486-9. PubMed ID: 13433422
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats.
    Kamocka M; Kaplinska K; Mielicki WP
    Clin Exp Med; 2006 Oct; 6(3):119-23. PubMed ID: 17061060
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.